H2020Doctoral network2019–2022

Phys2BioMed · Biomechanics in health and disease: advanced physical tools for innovative early diagnosis

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2019-01-01 → 2022-12-31
EU contribution
€3,911,783
Participants
16
Scheme
MSCA-ITN

Lines connect the coordinator with its partners.

Results in brief

Biomechanics in health and disease: advanced physical tools for innovative early diagnosis

The identification and understanding of the physical and chemical determinants of diseases, typically at the level of tissues and their constituents (cells and extracellular matrix, ECM), represent a potential breakthrough in nanomedicine because it would allow developing effective early diagnostic methods and, ideally, preventive strategies. In particular, there is a growing evidence of the role of mechanics in cell biology related to various stresses and diseases. Phys2BioMed aims therefore at identifying and collecting mechanical markers, which allow for the early detection of cell and tissue dysfunction and the onset of diseases. Phys2BioMed will offer excellent interdisciplinary and cross-sectoral training to a team of motivated early stage researchers (ESRs) on the application of cutting-edge physical tools for the mechanical phenotyping of cells and tissues of clinical relevance, aiming at developing novel early-diagnostic tools. A key element is the peer-to-peer collaboration of research academic institutions with industries and world-leading medical and clinical centers, who will highlight unmet clinical needs. Phys2BioMed will provide scientific and technological outcomes on biomechanics, and the mechanical determinants of diseases, by: - Defining standardized procedures for nanomechanical measurements, and the main features of new-generation instrumentation optimized for the mechanical phenotyping of clinical specimens; - providing, in the longer-term, the platform and know-how to build a data bank of mechanical fingerprints of diseases, for the development of effective early-diagnostic tools. Specific scientific and technological objectives of the research programme: - To establish the mechanical and rheological fingerprints of cells and tissues and their alterations in diseases. Phys2BioMed will produce comprehensive nano-mechanical and rheological phenotypes of cells and tissues to define mechanical fingerprints of specific diseases. The main approach used will be based on atomic force microscopy (AFM) coupled to different methods such as microfluidic cytometry, non-AFM nano-indentation and structural inspection. - To establish procedures, models, and standards for assessments of cell and tissue nano-mechanical properties. The approach will reside in defining standard procedures for mechanical tests, sample preparation and data analysis. Databases will be launched to be open to the scientific community. - To correlate the output of the mechanical and rheological phenotyping of clinical samples (ECMs, cells, tissues) to specific clinical features of the selected diseases, so to define heuristic mechanical fingerprints to be used as early-diagnostic cues.

Data: CORDIS, © European Union

Project objective

Phys2BioMed will offer excellent interdisciplinary and cross-sectoral training to a team of motivated early stage researchers (ESRs) on the application of cutting-edge physical tools for the mechanical phenotyping of cells and tissues of clinical relevance, aiming at developing novel early-diagnostic tools. The Phys2BioMed network will merge diverse competences at European level, from different fields like nanoscience and nanotechnology, physics, biology, and medicine, and will expose ESRs to the non academic and private sector. A key element of the project is the peer-to-peer collaboration of research academic institutions with industries and world-leading medical and clinical centers; these are the main actors of the global challenge against diseases, and within Phys2BioMed they will highlight unmet clinical needs, and actively cooperate with academic colleagues for developing novel diagnostic strategies. ESRs will be trained-through-research by world-leading junior and senior PIs, and will benefit of lecture courses, dedicated international schools and workshops, and topical conferences. Secondments to other nodes of the network will represent the main and more effective channel of dissemination and cross-fertilization of competences, ideas, and knowledge within the network. Besides training talented young scientists, ready to work at the boundary of diverse disciplines in the field of nanomedicine, Phys2BioMed will provide scientific and technological outcomes on biomechanics, and the mechanical determinants of diseases. Technology-wise, it will define standardized procedures for nanomechanical measurements, and the definition of the main features of new-generation instrumentation optimized for the mechanical phenotyping of clinical specimens. In the longer-term, Phys2BioMed will provide the platform and know-how to build a data bank of mechanical fingerprints of diseases, setting the ground for the development of effective early-diagnostic tools.

Original text from CORDIS.

Participants

  • UNIVERSITA DEGLI STUDI DI MILANO · MilanoCoordinatorItaly
  • BIOMECA · LyonFrance
  • CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE · LilleFrance
  • CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE · La TroncheFrance
  • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS · ParisFrance
  • COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES · ParisFrance
  • FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN-NUERNBERG · ErlangenGermany
  • FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA · BarcelonaSpain
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE · ParisFrance
  • OPTICS11 B.V. · AMSTERDAMNetherlands
  • OSPEDALE SAN RAFFAELE SRL · MilanoItaly
  • THE HENRYK NIEWODNICZANSKI INSTITUTE OF NUCLEAR PHYSICS, POLISH ACADEMY OF SCIENCES · KRAKOWPoland
  • UNIVERSITAET BREMEN · BremenGermany
  • UNIVERSITAET MUENSTER · MuensterGermany
  • UNIWERSYTET JAGIELLONSKI · KrakowPoland
  • VMICRO · VILLENEUVE D'ASCQFrance

Links

Data: CORDIS, © European Union